Simplex Trading’s Regulus Therapeutics RGLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,622
| Closed | -$5.99K | – | 9400 |
|
|
2024
Q2 | $6K | Sell |
3,622
-71,828
| -95% | -$167K | ﹤0.01% | 7793 |
|
|
2024
Q1 | $217K | Buy |
+75,450
| New | +$123K | ﹤0.01% | 4760 |
|
|
2023
Q1 | – | Sell |
-301
| Closed | -$398 | – | 9950 |
|
|
2022
Q4 | $0 | Buy |
+301
| New | +$473 | ﹤0.01% | 10214 |
|
|
2022
Q3 | – | Sell |
-527
| Closed | -$949 | – | 10723 |
|
|
2022
Q2 | $1K | Buy |
+527
| New | +$1.28K | ﹤0.01% | 9654 |
|
|
2022
Q1 | – | Sell |
-105
| Closed | -$273 | – | 11234 |
|
|
2021
Q4 | $0 | Sell |
105
-1,727
| -94% | -$7.67K | ﹤0.01% | 11286 |
|
|
2021
Q3 | $15K | Sell |
1,832
-200
| -10% | -$1.47K | ﹤0.01% | 8672 |
|
|
2021
Q2 | $16K | Buy |
+2,032
| New | +$22.7K | ﹤0.01% | 8780 |
|
|
2020
Q4 | – | Sell |
-2,937
| Closed | -$21.6K | – | 8943 |
|
|
2020
Q3 | $15K | Buy |
2,937
+1,406
| +92% | +$9.26K | ﹤0.01% | 6564 |
|
|
2020
Q2 | $10K | Hold |
1,531
| – | – | ﹤0.01% | 6660 |
|
|
2020
Q1 | $7K | Buy |
+1,531
| New | +$13.3K | ﹤0.01% | 6687 |
|
|
2017
Q4 | – | Sell |
-9
| Closed | -$1.14K | – | 6561 |
|
|
2017
Q3 | $1K | Buy |
9
+7
| +350% | +$880 | ﹤0.01% | 5547 |
|
|
2017
Q2 | $0 | Buy |
+2
| New | +$334 | ﹤0.01% | 6677 |
|
|
2016
Q4 | – | Sell |
-7
| Closed | -$2K | – | 6403 |
|
|
2016
Q3 | $2K | Buy |
+7
| New | +$2.88K | ﹤0.01% | 5025 |
|
|
2016
Q2 | – | Sell |
-123
| Closed | -$88.1K | – | 6353 |
|
|
2016
Q1 | $102K | Buy |
123
+94
| +324% | +$74.8K | 0.01% | 1339 |
|
|
2015
Q4 | $30K | Buy |
+29
| New | +$29.1K | ﹤0.01% | 2341 |
|
|
2015
Q3 | – | Sell |
-275
| Closed | -$282K | – | 6073 |
|
|
2015
Q2 | $362K | Buy |
275
+270
| +5,400% | +$436K | 0.03% | 499 |
|
|
2015
Q1 | $10K | Buy |
+5
| New | +$10.9K | ﹤0.01% | 2958 |
|
Simplex Trading's RGLS Position: Q3 2024 in Review
Simplex Trading sold out of Regulus Therapeutics (RGLS) in Q3 2024, closing a stake of 3,622 shares — an estimated $5.99K sold.
Simplex Trading first reported a position in RGLS in Q1 2015 and held it in 17 quarters. The position peaked at $362K in Q2 2015. 70 funds tracked by Wall St. Rank hold RGLS as of Q3 2024.
- Simplex Trading reported no remaining Regulus Therapeutics position as of Q3 2024 after selling out during the quarter.
- Simplex Trading sold 3,622 Regulus Therapeutics shares in Q3 2024, an estimated $5.99K.
- Simplex Trading first reported a position in Regulus Therapeutics in Q1 2015 and held it in 17 quarters.
- Simplex Trading's Regulus Therapeutics position peaked at $362K in Q2 2015.
- 70 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q3 2024.
Based on Simplex Trading's 13F filing for Q3 2024, filed 8 Nov 2024.